litlas
ログインアカウント作成

Kenneth E. Thummel

1990–2024 年に発表

121
論文数
22,364
被引用数
85
h 指数
121
i10 指数

被引用数

Kenneth E. Thummel の年別被引用数1983 年: 被引用 4 件1989 年: 被引用 2 件1990 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 5 件1994 年: 被引用 13 件1995 年: 被引用 64 件1996 年: 被引用 51 件1997 年: 被引用 101 件1998 年: 被引用 107 件1999 年: 被引用 139 件2000 年: 被引用 144 件2001 年: 被引用 183 件2002 年: 被引用 224 件2003 年: 被引用 296 件2004 年: 被引用 338 件2005 年: 被引用 355 件2006 年: 被引用 337 件2007 年: 被引用 262 件2008 年: 被引用 265 件2009 年: 被引用 247 件2010 年: 被引用 206 件2011 年: 被引用 179 件2012 年: 被引用 179 件2013 年: 被引用 183 件2014 年: 被引用 140 件2015 年: 被引用 119 件2016 年: 被引用 104 件2017 年: 被引用 100 件2018 年: 被引用 93 件2019 年: 被引用 387 件2020 年: 被引用 360 件2021 年: 被引用 374 件2022 年: 被引用 234 件2023 年: 被引用 165 件2024 年: 被引用 341 件2025 年: 被引用 111 件1984〜1988 年は被引用が無いため表示していません1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,084 件、この内訳の 33.4%イギリス: 引用元論文 480 件、この内訳の 7.7%ドイツ: 引用元論文 348 件、この内訳の 5.6%中国: 引用元論文 310 件、この内訳の 5%日本: 引用元論文 284 件、この内訳の 4.5%カナダ: 引用元論文 251 件、この内訳の 4%オランダ: 引用元論文 233 件、この内訳の 3.7%イタリア: 引用元論文 197 件、この内訳の 3.2%フランス: 引用元論文 178 件、この内訳の 2.8%スウェーデン: 引用元論文 169 件、この内訳の 2.7%スイス: 引用元論文 144 件、この内訳の 2.3%オーストラリア: 引用元論文 139 件、この内訳の 2.2%
0%33.4%その他 22.9%

機関

分野

  • Medicine43.9%
  • Pharmacology, Toxicology and Pharmaceutics39.4%
  • Biochemistry, Genetics and Molecular Biology8.5%
  • Engineering2.1%
  • Computer Science2%
  • Environmental Science0.8%
  • その他3.3%

トピック

  • Pharmacogenetics and Drug Metabolism16.5%
  • Drug Transport and Resistance Mechanisms9.5%
  • Pharmacological Effects and Toxicity Studies4.4%
  • Drug-Induced Hepatotoxicity and Protection3%
  • Computational Drug Discovery Methods2.9%
  • Renal Transplantation Outcomes and Treatments1.8%
  • その他61.9%

共著者

全論文

検索で開く
  1. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

    著者: Peter Kuehl, Jiong Zhang, Yvonne Lin, Jatinder K. Lamba, Mahfoud Assem, John D. Schuetz, Paul B. Watkins, Ann K. Daly, Steven Wrighton, Stephen D. Hall, P Maurel, Mary V. Relling, Cynthia Brimer, Kazuto Yasuda, Raman Venkataramanan, Stephen C. Strom, Kenneth E. Thummel, Mark S. Boguski, Erin G. Schuetz - Nature Genetics 2001 被引用: 2,161

  2. Development of a microphysiological model of human kidney proximal tubule function

    著者: Elijah J. Weber, Alenka Chapron, Brian D. Chapron, Jenna L. Voellinger, Kevin A. Lidberg, Catherine K. Yeung, Zhican Wang, Yoshiyuki Yamaura, Dale W. Hailey, Thomas Neumann, Danny D. Shen, Kenneth E. Thummel, Kimberly A. Muczynski, Jonathan Himmelfarb, Edward J. Kelly - Kidney International 2016 被引用: 267

  3. Evaluation of Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants

    著者: Sumit Bansal, C. Austin Zamarripa, Tory R. Spindle, Elise M. Weerts, Kenneth E. Thummel, Ryan G. Vandrey, Mary F. Paine, Jashvant D. Unadkat - Clinical Pharmacology & Therapeutics 2023 被引用: 62

  4. Genetic contribution to variable human CYP3A-mediated metabolism

    著者: Jatinder K. Lamba, Yvonne S. Lin, Erin G. Schuetz, Kenneth E. Thummel - Advanced Drug Delivery Reviews 2002 被引用: 992

  5. Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants

    著者: Rakshit S. Tanna, James Nguyen, Deena L. Hadi, Preston K. Manwill, Laura Flores‐Bocanegra, Matthew E. Layton, John R. White, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel, Mary F. Paine - Pharmaceutics 2022 被引用: 64

  6. Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model

    著者: Seung‐been Lee, Marsha M. Wheeler, Karynne Patterson, Sean McGee, Rachel Dalton, Erica L. Woodahl, Andrea Gaedigk, Kenneth E. Thummel, Deborah A. Nickerson - Genetics in Medicine 2018 被引用: 151

  7. CYP3A4 mutation causes vitamin D–dependent rickets type 3

    著者: Jeffrey D. Roizen, Dong Li, Lauren O’Lear, M K Javaid, Nicholas J Shaw, Peter R. Ebeling, Hanh H. Nguyen, Christine Rodda, Kenneth E. Thummel, Tom D. Thacher, Håkon Håkonarson, Michael A. Levine - Journal of Clinical Investigation 2018 被引用: 118

  8. Cyp2e1 Activity Before and After Weight Loss in Morbidly Obese Subjects With Nonalcoholic Fatty Liver Disease

    著者: Maurice G. Emery, Jeannine M. Fisher, Jenny Chien, Evan D. Kharasch, Patchen Dellinger, Kris V. Kowdley, Kenneth E. Thummel - Hepatology 2003 被引用: 176

  9. Interindividual Variability in Cytochrome P450–Mediated Drug Metabolism

    著者: T. S. Tracy, Amarjit S. Chaudhry, Bhagwat Prasad, Kenneth E. Thummel, Erin G. Schuetz, Xiao‐bo Zhong, Yin-Chun Tien, Hyunyoung Jeong, Xian Pan, Laura M. Shireman, Jessica Tay-Sontheimer, Yvonne S Lin - Drug Metabolism and Disposition 2015 被引用: 175

  10. Drug Metabolism and Transport During Pregnancy: How Does Drug Disposition Change during Pregnancy and What Are the Mechanisms that Cause Such Changes?

    著者: Nina Isoherranen, Kenneth E. Thummel - Drug Metabolism and Disposition 2013 被引用: 208

  11. Interplay between vitamin D and the drug metabolizing enzyme CYP3A4

    著者: Zhican Wang, Erin G. Schuetz, Yang Xu, Kenneth E. Thummel - The Journal of Steroid Biochemistry and Molecular Biology 2012 被引用: 123

  12. Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences

    著者: Seung‐been Lee, Marsha M. Wheeler, Kenneth E. Thummel, Deborah A. Nickerson - Clinical Pharmacology & Therapeutics 2019 被引用: 92

  13. Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail

    著者: James Nguyen, Dandan Tian, Rakshit S. Tanna, Deena L. Hadi, Sumit Bansal, Justina C. Calamia, Christopher M. Arian, Laura M. Shireman, Bálint Molnár, Miklós Horváth, Joshua J. Kellogg, Matthew E. Layton, John R. White, Nadja B. Cech, Richard D. Boyce, Jashvant D. Unadkat, Kenneth E. Thummel, Mary F. Paine - Clinical Pharmacology & Therapeutics 2020 被引用: 39

  14. Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom

    著者: Rakshit S. Tanna, James Nguyen, Deena L. Hadi, Matthew E. Layton, John R. White, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel, Mary F. Paine - Clinical Pharmacology & Therapeutics 2023 被引用: 27

  15. Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum

    著者: Mary F. Hébert, Songmao Zheng, Karen Hays, Danny D. Shen, Connie L. Davis, Jason G. Umans, Menachem Miodovnik, Kenneth E. Thummel, Thomas R. Easterling - Transplantation 2012 被引用: 144

  16. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations

    著者: Colin P. Hawkes, Dong Li, Håkon Håkonarson, Kevin Meyers, Kenneth E. Thummel, Michael A. Levine - The Journal of Clinical Endocrinology & Metabolism 2017 被引用: 100

  17. Translating Kratom-Drug Interactions: From Bedside to Bench and Back

    著者: Rakshit S. Tanna, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel, Mary F. Paine - Drug Metabolism and Disposition 2023 被引用: 24

  18. New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

    著者: Shiew‐Mei Huang, John M. Strong, Lei Zhang, Kellie S. Reynolds, Srikanth C. Nallani, Robert Temple, Sophia Abraham, Sayed Al Habet, Raman Baweja, Gilbert J. Burckart, Sang M. Chung, Philip M. Colangelo, David M. Frucht, Martin D. Green, Paul Hepp, Elena Karnaukhova, Hee Gyeong Ko, Jang-ik Lee, Patrick Marroum, Janet M. Norden, Wei Qiu, Atiqur Rahman, Solomon Sobel, Toni Stifano, Kenneth E. Thummel, Xiaoxiong Wei, Sally Usdin Yasuda, Jenny Zheng, Hong Zhao, Lawrence J. Lesko - The Journal of Clinical Pharmacology 2008 被引用: 400

  19. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

    著者: Kelly A. Birdwell, Brian S. Decker, Julia M. Barbarino, Josh F. Peterson, C. Michael Stein, Wolfgang Sadée, Daqing Wang, Alexander A. Vinks, Yijing He, Jesse J. Swen, J. Steven Leeder, RHN van Schaik, Kenneth E. Thummel, Teri E. Klein, Kelly E. Caudle, Iain MacPhee - 2015 被引用: 88

  20. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*

    著者: Kenneth E. Thummel, Diarmuid O’Shea, Mary F. Paine, Danny D. Shen, Kent L. Kunze, James D. Perkins, G. Wilkinson - Clinical Pharmacology & Therapeutics 1996 被引用: 619

  21. Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3

    著者: Kenneth E. Thummel, Cynthia Brimer, Kazuto Yasuda, Jaideep V. Thottassery, Tauri Senn, Yvonne Lin, Hitoshi Ishizuka, Evan D. Kharasch, John D. Schuetz, Erin G. Schuetz - Molecular Pharmacology 2001 被引用: 324

  22. ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION

    著者: Nina Isoherranen, Kent L. Kunze, Kyle E. Allen, Wendel L. Nelson, Kenneth E. Thummel - Drug Metabolism and Disposition 2004 被引用: 275

  23. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport

    著者: Catherine K. Yeung, Danny D. Shen, Kenneth E. Thummel, Jonathan Himmelfarb - Kidney International 2013 被引用: 213

  24. An Inducible Cytochrome P450 3A4-Dependent Vitamin D Catabolic Pathway

    著者: Zhican Wang, Yvonne S. Lin, Xi Zheng, Tauri Senn, Takanori Hashizume, Michele Scian, Leslie J. Dickmann, Sidney D. Nelson, Thomas A. Baillie, Mary F. Hébert, David K. Blough, Connie L. Davis, Kenneth E. Thummel - Molecular Pharmacology 2011 被引用: 114